Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Davidson

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 3, 2012
New psychoactive substancesColin Davidson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2015
The potential utility of some legal highs in CNS disordersColin Davidson, Fabrizio Schifano
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbensColin Davidson, John Ramsey
Neurotoxicology|June 25, 2013
Amphetamine makes caudate tissue more susceptible to oxygen and glucose deprivationAnand Tana, Colin Davidson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2012
Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatmentDaniel I Brierley, Colin Davidson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 9, 2015
Drugs of abuse--its not all bad newsColin Davidson, Francisco Molina-Holgado
Journal of Psychopharmacology (Oxford, England)|October 19, 2012
Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shellDaniel I Brierley, Colin Davidson
British Journal of Clinical Pharmacology|February 12, 2020
How preclinical studies have influenced novel psychoactive substance legislation in the UK and EuropeRaquel Santos-Toscano, Amira Guirguis, Colin Davidson
Neuroscience Letters|March 18, 2015
Persistent conditioned place preference to cocaine and withdrawal hypo-locomotion to mephedrone in the flatworm planariaClaire V Hutchinson, Jose Prados, Colin Davidson
European Journal of Pharmacology|September 24, 2004
The NK(1) receptor antagonist WIN51708 reduces sensitization after chronic cocaineColin Davidson, Tong H Lee, Everett H Ellinwood
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 3, 2012
New psychoactive substancesColin Davidson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2015
The potential utility of some legal highs in CNS disordersColin Davidson, Fabrizio Schifano
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Desoxypipradrol is more potent than cocaine on evoked dopamine efflux in the nucleus accumbensColin Davidson, John Ramsey
Neurotoxicology|June 25, 2013
Amphetamine makes caudate tissue more susceptible to oxygen and glucose deprivationAnand Tana, Colin Davidson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2012
Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatmentDaniel I Brierley, Colin Davidson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 9, 2015
Drugs of abuse--its not all bad newsColin Davidson, Francisco Molina-Holgado
Journal of Psychopharmacology (Oxford, England)|October 19, 2012
Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shellDaniel I Brierley, Colin Davidson
British Journal of Clinical Pharmacology|February 12, 2020
How preclinical studies have influenced novel psychoactive substance legislation in the UK and EuropeRaquel Santos-Toscano, Amira Guirguis, Colin Davidson
Neuroscience Letters|March 18, 2015
Persistent conditioned place preference to cocaine and withdrawal hypo-locomotion to mephedrone in the flatworm planariaClaire V Hutchinson, Jose Prados, Colin Davidson
European Journal of Pharmacology|September 24, 2004
The NK(1) receptor antagonist WIN51708 reduces sensitization after chronic cocaineColin Davidson, Tong H Lee, Everett H Ellinwood
Pageof 5